| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $74.7M | +26.9% |
| Cost of Revenue | $71.0M | +56.8% |
| R&D Expense | $475.3M | +51.2% |
| SG&A Expense | $176.6M | -0.9% |
| Operating Income | -$648.1M | -35.3% |
| Pre-tax Income | -$644.9M | -38.8% |
| Income Tax | -$136K | +87.9% |
| Net Income | -$644.8M | -39.1% |
| EPS (Basic) | -$1.44 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $743.3M | +25.1% |
| Current Assets | $812.8M | +13.8% |
| Total Assets | $1.47B | +1.8% |
| Current Liabilities | $147.7M | -21.2% |
| Long-term Debt | $9.6M | -49.7% |
| Total Liabilities | $343.3M | -17.0% |
| Stockholders' Equity | $1.13B | +9.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$371.8M | -3.5% |
| Capital Expenditures | $6.5M | -52.8% |
| Investing Cash Flow | -$16.9M | -106.5% |
| Financing Cash Flow | $521.5M | +71.5% |
| Free Cash Flow | -$378.3M | -1.5% |
| +14.8% |
| EPS (Diluted) | -$1.44 | +14.8% |